You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 12, September 24, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Medical Practice
 •Medical Practice, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Low Levels of Awareness of Pharmaceutical Cost-Assistance Programs Among Inner-City Seniors

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Although Medicare Part D has improved access to prescription medications, drug costs remain a problem for many older adults.1 The Medicare low-income subsidy program (Extra Help) and state-sponsored pharmaceutical assistance programs can help seniors mitigate this problem by providing cost-sharing or Part D premium assistance, yet they are underenrolled by as much as 50%,2-3 possibly due to lack of awareness. We assessed a diverse sample of inner-city seniors for rates of awareness of New York State's Elderly Pharmaceutical Insurance Coverage (EPIC), established in 1987, and Extra Help, established in 2006.

Methods

We recruited independently living adults aged 60 years or older by convenience sampling from 20 senior centers and residential complexes in New York, New York, between June and September 2007. Sites were selected from zip code areas with median annual household incomes below $50 000. Men were oversampled and interviews were conducted in English and Spanish. Race and . . . [Full Text of this Article]

Alex D. Federman, MD, MPH
alex.federman@mssm.edu
Division of General Internal Medicine
Mount Sinai School of Medicine
New York, New York

Dana Gelb Safran, ScD
The Health Institute
Institute for Clinical Research and Health Policy Studies
Tufts-New England Medical Center
Boston, Massachusetts

Salomeh Keyhani, MD, MPH
Department of Health Policy

Albert L. Siu, MD, MSPH
Brookdale Department of Geriatrics and Adult Development

Ethan A. Halm, MD, MPH
Division of General Internal Medicine
Mount Sinai School of Medicine



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.